<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01297855</url>
  </required_header>
  <id_info>
    <org_study_id>SirirajCEU51-001</org_study_id>
    <nct_id>NCT01297855</nct_id>
  </id_info>
  <brief_title>Colistin Plus Rifampicin in MDR P. Aeruginosa and A. Baumanii</brief_title>
  <official_title>Randomized Controlled Trial of Colistin Versus Colistin Plus Rifampicin in MDR P.Aeruginosa and A.Baumanii</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mahidol University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mahidol University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In Siriraj Hospital, Colistin alone for treatment of MDR. A.baumanii or P.aeruginosa
      contributed to mortality 45%. In vitro studies revealed synergism of Rifampicin and Colistin.

      In this study, patients with documented MDR. P.aeruginosa or A.baumanii will be allocated to
      receive Colistin alone and another group will receive Colistin plus Rifampicin.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>June 2010</start_date>
  <completion_date type="Anticipated">August 2012</completion_date>
  <primary_completion_date type="Anticipated">May 2012</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>number of subjects with cure or improvement</measure>
    <time_frame>up to day 28</time_frame>
    <description>Cure Improvement Worse Death</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>number of subjects with eradication of causative bacteria</measure>
    <time_frame>up to day 28</time_frame>
    <description>Eradication Persistence Superinfection</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">130</enrollment>
  <condition>Drug Safety</condition>
  <arm_group>
    <arm_group_label>Colistin</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Colistate</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Colistin plus Rifampicin</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Colistate Rifampin</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Colistin</intervention_name>
    <description>Colistimethate Sodium dose 2.5-5mg/kg/day</description>
    <arm_group_label>Colistin</arm_group_label>
    <other_name>Colistate</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Colistin plus Rifampicin</intervention_name>
    <description>Colistin 2.5 to 5 mg/ Kg/ day Rifampin 10 mg/ Kg/ day</description>
    <arm_group_label>Colistin plus Rifampicin</arm_group_label>
    <other_name>Colistate</other_name>
    <other_name>Rifampin</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age&gt;18 years

          -  Hospitalized to Siriraj Hospital

          -  Infection with MDR A.baumanii or P.aeruginosa

          -  Nescessary for treatment with Colistin

          -  Patient agrees to participate by giving written informed consent.

        Exclusion Criteria:

          -  pregnancy or lactating mother

          -  Colistin or Rifampicin allergy

          -  Active hepatic disease or abnormal liver function test

          -  patient who suspected infection with mycobacterium tuberculosis

          -  patient who can not drug by enteral feeding
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sukij Piyasirisilp, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Siriraj Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Visanu Thamlikitkul, Professor</last_name>
    <phone>662 419 7000</phone>
    <phone_ext>6626</phone_ext>
    <email>sivth@mahidol.ac.th</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Sunee Thanakhumtorn</last_name>
    <phone>662 419 7000</phone>
    <phone_ext>6616</phone_ext>
    <email>srstn@mahidol.ac.th</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Division of Infectious disease and Tropical Medicine, Department of Medicine, Faculty of Medicine Siriraj Hospital</name>
      <address>
        <city>Bangkoknoi</city>
        <state>Bangkok</state>
        <zip>10700</zip>
        <country>Thailand</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Visanu Thamlikitkul, Professor</last_name>
      <phone>662 419 7000</phone>
      <phone_ext>6626</phone_ext>
      <email>sivth@mahidol.ac.th</email>
    </contact>
    <contact_backup>
      <last_name>Sunee Thanakhumtorn</last_name>
      <phone>662 419 7000</phone>
      <phone_ext>6616</phone_ext>
      <email>srstn@mahidol.ac.th</email>
    </contact_backup>
    <investigator>
      <last_name>Sukij Piyasirisilp, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Thailand</country>
  </location_countries>
  <verification_date>December 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 20, 2009</study_first_submitted>
  <study_first_submitted_qc>February 15, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 17, 2011</study_first_posted>
  <last_update_submitted>December 29, 2011</last_update_submitted>
  <last_update_submitted_qc>December 29, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 2, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mahidol University</investigator_affiliation>
    <investigator_full_name>Visanu Thamlikitkul</investigator_full_name>
    <investigator_title>Department of Medicine, Faculty of Medicine Siriraj Hospital, Bangkok, Thailand</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rifampin</mesh_term>
    <mesh_term>Colistin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

